Incorporation of BRCA1 testing into prenatal carrier screening for hereditary breast and ovarian cancer prevention should take carrier rates into account

Am J Obstet Gynecol. 2024 Dec 11:S0002-9378(24)01181-5. doi: 10.1016/j.ajog.2024.12.004. Online ahead of print.
No abstract available

Publication types

  • Letter